UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Cannabis Pharmacogenomics: A Path to Personalized Medicine

Current issues in molecular biology, 2023-04, Vol.45 (4), p.3479-3514

2023

Volltextzugriff (PDF)

Non-linear plasma protein binding of cannabidiol

Journal of cannabis research, 2024-06, Vol.6 (1), p.27-5, Article 27

2024

Volltextzugriff (PDF)

Autism and associated disorders: cannabis as a potential therapy

Frontiers in bioscience (Elite edition), 2022-01, Vol.14 (1), p.1

2022

Volltextzugriff (PDF)

Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy

Parkinson's disease, 2016-01, Vol.2016, p.1279042-19

2016

Volltextzugriff (PDF)

Preclinical Studies of RUC-4, a Novel Platelet αIIbβ3 Antagonist, in Non-Human Primates and With Human Platelets

Journal of clinical and translational science, 2019-06, Vol.3 (2-3), p.65-74

2019

Volltextzugriff (PDF)

Plasma protein binding of cannabidiol

Phytotherapy research, 2022-07, Vol.36 (7), p.2683-2685

2022

Volltextzugriff (PDF)

Effects of trimethoprim on the clearance of apricitabine, a deoxycytidine analog reverse transcriptase inhibitor, and Lamivudine in the isolated perfused rat kidney

The Journal of pharmacology and experimental therapeutics, 2006-11, Vol.319 (2), p.941

2006

Volltextzugriff (PDF)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine

Pharmacogenomics and personalized medicine, 2020-01, Vol.13, p.531-542

2020

Volltextzugriff (PDF)

Pharmacokinetic (PK) and Pharmacodynamic (PD) Studies of RUC-4 Succinate, a Novel αIIbβ3 Pure Antagonist for First Point of Contact Treatment of ST Segment Elevated Myocardial Infarction (STEMI)

Blood, 2018-11, Vol.132 (Supplement 1), p.1243-1243

2018

Volltextzugriff (PDF)

Physicochemical characterization, solubilization, and stabilization of a macrolide antibiotic

Journal of drug delivery science and technology, 2020-06, Vol.57, p.101755, Article 101755

2020

Volltextzugriff (PDF)

Studying the factors that impact the dissolution characteristic of complex drug product

Pharmaceutical development and technology, 2019-11, Vol.24 (10), p.1200-1209

2019

Volltextzugriff (PDF)

Determination of intestinal permeability of rigosertib (ON 01910.Na, Estybon): correlation with systemic exposure

Journal of pharmacy and pharmacology, 2013-07, Vol.65 (7), p.960-969

2013

Volltextzugriff (PDF)

A novel class of ion displacement ligands as antagonists of the alpha IIb beta 3 receptor that limit conformational reorganization of the receptor

Bioorganic & medicinal chemistry letters, 2014-02, Vol.24 (4), p.1148-1153

2014

Volltextzugriff (PDF)

A novel class of ion displacement ligands as antagonists of the αIIbβ3 receptor that limit conformational reorganization of the receptor

Bioorganic & medicinal chemistry letters, 2014-02, Vol.24 (4), p.1148-1153

2014

Volltextzugriff (PDF)

Renal excretion of apricitabine in rats: ex vivo and in vivo studies

European journal of drug metabolism and pharmacokinetics, 2011-09, Vol.36 (3), p.141-150

2011

Volltextzugriff (PDF)

Drug interactions screening with apricitabine in the kidney

Babayeva, Mariana

2008

Volltextzugriff (PDF)

Studying the factors that impact the dissolution characteristic of complex drug product

Pharmaceutical Development and Technology, 2019, Vol.24 (10), p.1200-1209

2019

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(14)

Publikationsform

Sprache

Englisch
(17)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Pharmacology & Pharmacy
(9)
Animals
(3)
Male
(3)
Rats
(3)
Rats, Sprague-Dawley
(3)
Review
(3)
Cannabis
(2)
Cbd
(2)
Chemistry, Medicinal
(2)
Compression
(2)
Cushion Coat
(2)
Deoxycytidine - Analogs & Derivatives
(2)
Deoxycytidine - Pharmacokinetics
(2)
Dose-Response Relationship, Drug
(2)
Drug Interactions
(2)
Ethyl Cellulose
(2)
Extended Release
(2)
Health Aspects
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cannabis Pharmacogenomics: A Path to Personalized Medicine

Non-linear plasma protein binding of cannabidiol

Autism and associated disorders: cannabis as a potential therapy

Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy

Preclinical Studies of RUC-4, a Novel Platelet αIIbβ3 Antagonist, in Non-Human Primates and With Human Platelets

Plasma protein binding of cannabidiol

Effects of trimethoprim on the clearance of apricitabine, a deoxycytidine analog reverse transcriptase inhibitor, and Lamivudine in the isolated perfused rat kidney

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine

Pharmacokinetic (PK) and Pharmacodynamic (PD) Studies of RUC-4 Succinate, a Novel αIIbβ3 Pure Antagonist for First Point of Contact Treatment of ST Segment Elevated Myocardial Infarction (STEMI)

Physicochemical characterization, solubilization, and stabilization of a macrolide antibiotic

Studying the factors that impact the dissolution characteristic of complex drug product

Determination of intestinal permeability of rigosertib (ON 01910.Na, Estybon): correlation with systemic exposure

A novel class of ion displacement ligands as antagonists of the alpha IIb beta 3 receptor that limit conformational reorganization of the receptor

A novel class of ion displacement ligands as antagonists of the αIIbβ3 receptor that limit conformational reorganization of the receptor

Renal excretion of apricitabine in rats: ex vivo and in vivo studies

Drug interactions screening with apricitabine in the kidney

Studying the factors that impact the dissolution characteristic of complex drug product

Suchergebnisse filtern